Front Row lecture series
From molecule to medicine: New therapies for cancer, heart disease and global health
Sean Joseph, PhD
Vice President of Translational Science and Early Clinical Development, Calibr-Skaggs Institute for Innovative Medicines
Wednesday, April 22, 2026
4:00 p.m. PT | 7:00 p.m. ET
Discovering a promising new drug is only the beginning—bringing it safely to people requires overcoming the so-called “Valley of Death” between laboratory breakthroughs and the patient bedside. In this free Front Row lecture, Calibr-Skaggs’ vice president of translational science and early clinical development, Sean Joseph, will reveal the complex journey medicines take and how the institute bridges this gap. Joseph will highlight Calibr-Skagg’s expansive pipeline, from regenerative medicines that repair damaged lung and heart tissue, to cancer immunotherapies, to treatments for global health threats like tuberculosis and malaria—pairing Scripps Research’s world-class discovery with Calibr-Skaggs’ deep translational expertise.
Reserve your seat! Join the community in person on the Scripps Research campus or attend virtually via Zoom webinar.